Understanding recovery from Alcohol Use Disorder
Clinical Course of Alcohol Use Disorder Recovery
This study is trying to understand how people recover from Alcohol Use Disorder by giving them 12 weeks of therapy and checking in on their progress over time.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of South Florida Academic / other |
| Locations | 1 site (Tampa, Florida) |
| Trial ID | NCT05607290 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to explore the recovery process for individuals with Alcohol Use Disorder (AUD) by establishing definitions of recovery and examining the dynamic nature of change during treatment. Participants will receive 12 weeks of psychotherapy and complete assessments after each session, as well as follow-up interviews at 3 and 6 months post-treatment. The study seeks to identify cognitive, behavioral, and emotional factors that influence recovery, thereby enhancing clinical decision-making and informing future research.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with Alcohol Use Disorder who are seeking treatment and can commute to the program site.
Not a fit: Patients with acute psychosis, severe cognitive impairment, or current drug use diagnoses other than nicotine or marijuana may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the recovery process for patients with Alcohol Use Disorder, leading to improved treatment strategies.
How similar studies have performed: While there have been studies on recovery from AUD, this approach focusing on the dynamic nature of recovery and the new NIAAA definitions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. current diagnosis of AUD (initial screening AUDIT ≥ 8, confirmed with diagnostic interview), 2. live within commuting distance of the program site, 3. provide informed consent. Exclusion Criteria: 1. acute psychosis or severe cognitive impairment (assessed via Psychotic Module of the M.I.N.I and Mini-Mental State ≤ 23), 2. current drug use diagnosis other than nicotine or marijuana use disorders, 3. lack of sufficient familiarity with the English language to comprehend the recruitment and consent procedures, 4. legally mandated to attend treatment
Where this trial is running
Tampa, Florida
- University of South Florida — Tampa, Florida, United States (Recruiting)
Study contacts
- Study coordinator: Robert C Schlauch, PhD
- Email: rschlauch@usf.edu
- Phone: 813-974-4767
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.